OTCMKTS:TSNDF

TerrAscend Q4 2024 Earnings Results & Report

TerrAscend logo
$0.30 -0.03 (-9.93%)
As of 11/20/2026 03:59 PM Eastern

TerrAscend beat analyst expectations on both earnings and revenue in its Q4 2024 results, released March 6, 2025. The company reported EPS of $0.01 versus the -$0.03 consensus estimate, while revenue of $74.35 million topped the $72.37 million estimate by $1.98 million.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes

TerrAscend EPS Results

Actual EPS
$0.01
Consensus EPS
-$0.03
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 8 quarters

TerrAscend Revenue Results

Actual Revenue
$74.35 million
Expected Revenue
$72.37 million
Beat/Miss
Beat by +$1.98 million
YoY Revenue Growth
N/A

Conference Call Resources

TerrAscend Q4 2024 Earnings FAQ

TerrAscend (OTCMKTS:TSNDF) reported earnings of $0.01 per share for Q4 2024, beating the consensus estimate of -$0.03. The report was announced on Thursday, March 6, 2025.

TerrAscend reported revenue of $74.35 million for Q4 2024, against a consensus estimate of $72.37 million.

TerrAscend Earnings Headlines

TerrAscend Reports Third Quarter 2026 Financial Results
Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
TerrAscend to Host Third Quarter 2026 Earnings Conference Call
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands.

The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.

TerrAscend serves both medical cannabis patients and adult-use consumers, with the products and services available varying by state and local regulations.

View TerrAscend Profile